Feature

Research Reports

Cost-Effectiveness of a Patient Navigation Program for Colorectal Cancer Screening

05/12/2017

Whitney C Rhodes, PhD, MSPA

Yvonne Kellar-Guenther, PhD

Arnold H Levinson, PhD, MJ

Andrea Dwyer, BS

R Mark Gritz, PhD

Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...

...

05/12/2017

Journal of Clinical Pathways

From the Field

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program

04/11/2017

Belinda R Avalos, MD

Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and...

...

04/11/2017

Journal of Clinical Pathways

Research Reports

Length of Stay and Costs of COPD: Analysis of Hospitalized Patients Treated With Arformoterol or Nebulized Short-Acting Beta2-Agonists

04/11/2017

Krithika Rajagopalan, PhD

Scott B Robinson, PhD

Frank R Ernst, PharmD, MS

Tina Hunter, PhD

Bernadette H Johnson, MBA

Vamsi K Bollu, PhD, MBA

Abstract: Hospitalization costs are substantial in chronic obstructive pulmonary disease (COPD). Little is known regarding the effect of long-acting beta2-agonists (LABAs) vs short-acting beta2-agonists (SABAs) on...

...

04/11/2017

Journal of Clinical Pathways

Research Reports

Clinical Pathways: A Current Snapshot, and the Journey Ahead

03/15/2017

Amy Schroeder, RPh

03/15/2017

Journal of Clinical Pathways

Perspectives

Patient-Reported Outcome Measurement in Clinical Practice: Overcoming Challenges to Continue Progress

02/13/2017

Rahma Warsame, MD

Michele Y Halyard, MD

Abstract: Health systems are evolving to make the patient the central focus of health care delivery. This has resulted in increased use and interest in patient-reported outcomes (PROs) to include the patient’s...

...

02/13/2017

Journal of Clinical Pathways

Special Article

The Solution to More Effective Diabetes Management: Better Products or Better Programs?

12/09/2016

Larry Blandford, PharmaD

Larry Blandford, PharmD, discusses the high costs of diabetes treatment and questions whether better products or better programs are the solution to more effective diabetes care.

Larry Blandford, PharmD,...

12/09/2016

Journal of Clinical Pathways

Special Article

Diabetes Clinical Pathways: Going Beyond Treatment Decisions

12/09/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

Diabetes guidelines increasingly go beyond treatment recommendations to take into account quality measures for diabetes care that exist within new value-based systems, addressing the roles and responsibilities of...

...

12/09/2016

Journal of Clinical Pathways

From the Field

A Novel Case Management System to Address Patient-Identified Concerns in Hematology and Oncology Clinical Pathways

10/12/2016

Rahma Warsame, MD

Joleen Hubbard, MD

Angela Dispenzieri, MD

Carrie Thompson, MD

Katrina Croghan, MS

Juliana Perez Botero, MD

Angelina Tan

Briant Fruth

Deirdre Pachman, MD

Veronica Lafky

Jeff Sloan, PhD

Abstract: Modern clinical practice places restrictions on the amount of information communicated in a typical office visit, impeding patient concerns from being adequately addressed. A point-of-care case management...

...

10/12/2016

Journal of Clinical Pathways

Research Reports

Associations Between Pre- and Post-Cancer Depression Diagnoses and End-of-Life Cancer Care Intensity

09/06/2016

Kathy Doan, MPH

Becca R Levy, PhD

Cary P Gross, MD

Shi-Yi Wang, MD, PhD

Abstract: Literature suggests that depression has adverse effects on health outcomes among patients with cancer. However, the associations between depression and end-of-life (EOL) cancer care are inconclusive. In...

...

09/06/2016

Journal of Clinical Pathways

Perspectives

In Defense of Meaningful Use: The Potential of Electronic Health Records Systems to Support Value-Based Care

08/02/2016

George A Gellert, MD, MPH, MPA

George S Conklin

S Luke Webster, MD

John A Gillean, MD

Lynn A Gibson

Abstract: The Meaningful Use Incentive Program from the Centers for Medicare & Medicaid Services (CMS) has successfully driven the adoption of electronic health records (EHRs). However, it has been criticized...

...

08/02/2016

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products